Neuroendocrine tumors of the thymus and mediastinum.

about

Neuroendocrine tumors of the thymus and mediastinum.

Item

http://www.wikidata.org/entity/Q47116688

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neuroendocrine tumors of the thymus and mediastinum.

@en

Neuroendocrine tumors of the thymus and mediastinum.

@nl

type

Item

label

Neuroendocrine tumors of the thymus and mediastinum.

@en

Neuroendocrine tumors of the thymus and mediastinum.

@nl

prefLabel

Neuroendocrine tumors of the thymus and mediastinum.

@en

Neuroendocrine tumors of the thymus and mediastinum.

@nl

P1476

Neuroendocrine tumors of the thymus and mediastinum.

@en

P2093

Alexander König

http://www.w3.org/2001/XMLSchema#string

Hanibal Bohnenberger

http://www.w3.org/2001/XMLSchema#string

Helen Dinter

http://www.w3.org/2001/XMLSchema#string

Philipp Ströbel

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties

Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.

Recurrent thymic carcinoid tumor in the pleural cavity. 2 cases of long-term survivors.

Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome.

Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.

Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis.

Clinicopathological analysis of 21 thymic neuroendocrine tumors.

Evaluation of the proposed International Association for the Study of Lung Cancer (IASLC)/International Thymic Malignancies Interest Group (ITMIG) staging revisions in thymic well-differentiated neuroendocrine carcinoma patients.

Activity of sunitinib in patients with advanced neuroendocrine tumors.

P304

S1448-S1457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.21037/JTD.2017.02.02

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 15

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29201448

http://www.w3.org/2001/XMLSchema#string

P932

5690954

http://www.w3.org/2001/XMLSchema#string